B

인바이오

352940KOSDAQ

59.3 / 100

Reference Date: 2026-09-08

Financial Score23.0 / 40
News Sentiment21.3 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Inbio produces and sells multifunctional pesticides, herbicides, and eco-friendly crop protection products, developing combined formulations to reduce farmers' workload and increase agricultural income. Responding to rising demand for labor-saving combined products, the company invests in R&D to differentiate its offerings through enhanced efficacy and user convenience, driving market growth.

Number of Employees

158people

Average Salary

44.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
21.51Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR
0.51Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
2.41Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
12.23Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲0.0% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲53.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -3.5% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 2,000Won52-week high 2,41052-week low 1,980
1-month return3.0Point

1m -0.5% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0
  • Neutral주주총회소집공고2026-09-04
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-26
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-18
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-14
  • Neutral반기보고서 (2026.06)2026-08-13